48 Biggest Movers From Yesterday
Gainers
Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.
31 Stocks Moving In Monday’s Mid-Day Session
Gainers
Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V
58 Biggest Movers From Friday
Gainers
CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.
Michael Burry Issues Grim Warning On Cryptocurrency, Stonks: Losses Will ‘Approach The Size Of Countries’
Scion Asset Management founder Michel Burry issued a series of tweets last week warning retail traders about cryptocurrencies and the so-called Stonks — the stocks unusually favored by retail investors — according to a Bloomberg News
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
CytRx Comments On Orphazyme Complete Response Letter From FDA
CytRx Corporation (OTCQB:CYTR) ("CytRx"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today noted that Orphazyme A/S
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; CAI International Shares Spike Higher
Toward the end of trading Friday, the Dow traded down 1.27% to 33,394.86 while the NASDAQ fell 0.92% to 14,031.05. The S&P also fell, dropping 1.03% to 4,178.31.